Repligen Corp. (RGEN)
166.56
+1.88
(+1.14%)
USD |
NASDAQ |
Sep 11, 14:42
Repligen Gross Profit (TTM) : 383.08M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 383.08M |
| March 31, 2026 | 365.24M |
| December 31, 2025 | 349.02M |
| September 30, 2025 | 331.32M |
| June 30, 2025 | 311.07M |
| March 31, 2025 | 301.72M |
| December 31, 2024 | 288.10M |
| September 30, 2024 | 289.76M |
| June 30, 2024 | 271.06M |
| March 31, 2024 | 269.88M |
| December 31, 2023 | 284.77M |
| September 30, 2023 | 296.12M |
| June 30, 2023 | 352.30M |
| March 31, 2023 | 395.45M |
| December 31, 2022 | 429.89M |
| September 30, 2022 | 440.18M |
| June 30, 2022 | 429.64M |
| March 31, 2022 | 410.14M |
| December 31, 2021 | 371.69M |
| September 30, 2021 | 328.82M |
| June 30, 2021 | 285.94M |
| March 31, 2021 | 240.73M |
| December 31, 2020 | 205.31M |
| September 30, 2020 | 184.74M |
| June 30, 2020 | 164.39M |
| Date | Value |
|---|---|
| March 31, 2020 | 150.74M |
| December 31, 2019 | 137.80M |
| September 30, 2019 | 128.65M |
| June 30, 2019 | 119.31M |
| March 31, 2019 | 106.37M |
| December 31, 2018 | 97.70M |
| September 30, 2018 | 90.98M |
| June 30, 2018 | 80.84M |
| March 31, 2018 | 74.64M |
| December 31, 2017 | 68.02M |
| September 30, 2017 | 61.73M |
| June 30, 2017 | 60.01M |
| March 31, 2017 | 58.20M |
| December 31, 2016 | 55.94M |
| September 30, 2016 | 53.40M |
| June 30, 2016 | 51.49M |
| March 31, 2016 | 47.97M |
| December 31, 2015 | 47.09M |
| September 30, 2015 | 44.49M |
| June 30, 2015 | 41.44M |
| March 31, 2015 | 37.52M |
| December 31, 2014 | 34.52M |
| September 30, 2014 | 35.99M |
| June 30, 2014 | 40.20M |
| March 31, 2014 | 43.00M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| BioLife Solutions, Inc. | 66.59M |
| Anika Therapeutics, Inc. | 75.00M |
| Danaher Corp. | 14.81B |
| Liquidia Corp. | 416.18M |
| Harmony Biosciences Holdings, Inc. | 700.15M |